POSTER - GATCLIQUID: Analysis of circulating tumor DNA for cancer detection and monitoring
19 January 2017

Detection of circulating tumor cells (CTCs) from blood samples has remained a major challenge due to overall low levels of circulating DNA, and an accurate quantification of mutated fragments present in a high background of wild-type fragments. This poster describes the GATCLIQUID services, including ONCOEXOME, ONCOPANEL and ONCOTARGET, for the early, non-invasive detection of cancer.